Anh Tuan Nguyen
About Anh Tuan Nguyen
Anh Tuan Nguyen serves as the Vice President of Business Development at Slingshot Biosciences, where he has been a co-founder since 2011. He has over 15 years of experience in life sciences, focusing on immunotherapies and strategic partner management.
Work at Slingshot
Anh Tuan Nguyen has been a Co-Founder of Slingshot Biosciences since 2011, contributing to the company's establishment and growth over 13 years in Berkeley, CA. He currently serves as Vice President of Business Development, a role he has held since 2022. Previously, he was involved in various capacities at Slingshot, including Lead Strategy and Corporate Development from 2021 to 2022 and Business Development and Operations from 2019 to 2021. His extensive experience at Slingshot reflects his commitment to advancing the company's mission in the life sciences sector.
Education and Expertise
Anh Tuan Nguyen earned a Bachelor of Science (BS) in Cell and Molecular Biology from Santa Clara University, where he also completed minors in Biotechnology and Philosophy from 2002 to 2006. His educational background supports his strong expertise in founding and seeding life science businesses. He has over 15 years of experience in flow cytometry, immunotherapies, and regulatory compliance, with a specialization in strategic partner management and business strategy within the immunotherapy sector.
Background
Before his tenure at Slingshot Biosciences, Anh Tuan Nguyen worked at several notable organizations. He was a Senior Researcher in Assay Development and Quality Control at Bavarian Nordic A/S from 2012 to 2014 and held roles at Gilead Sciences in Commercial Operations and Quality Assurance from 2014 to 2019. His early career included positions at Amyris Inc as Associate Scientist II and at Amgen as a Research Intern. This diverse background has contributed to his comprehensive understanding of the life sciences field.
Achievements
Throughout his career, Anh Tuan Nguyen has demonstrated a strong focus on intellectual property development within the life sciences sector. His roles have involved significant contributions to business strategy and operational management, particularly in the immunotherapy domain. His leadership at Slingshot Biosciences has been instrumental in driving the company's initiatives and partnerships, reflecting his commitment to innovation and growth in the industry.